CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog & Media
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Immune Checkpoint Inhibitors: What’s Next?

    What’s ahead beyond CTLA-4 and PD-1?

    February 9, 2015| Alexandra Mulvey
  • Progress Report from the Cancer Immunology “Dream Team”

    A group of "star" scientists are investigating new avenues of cancer immunotherapy that will benefit patients.

    January 23, 2015| Alexandra Mulvey
  • Could That Steak Be Giving You Cancer?

    A CRI postdoctoral fellow was part of the team investigating the relation of red meat to cancer…

    January 9, 2015| Matthew Tontonoz
  • Found: A Molecular Needle in the Cancer Haystack

    New research by CRI scientists shows how genomic methods can be used to create a personalized cancer…

    November 27, 2014| Matthew Tontonoz
  • Birth of the Lab Mouse

    Was the father of cancer immunotherapy also the father of the modern lab mouse?

    November 14, 2014| Matthew Tontonoz
  • CAR T Cell Therapy Surges Forward

    Researchers at the University of Pennsylvania publish latest results on an experimental immunotherapy using genetically engineered T…

    October 16, 2014| Matthew Tontonoz
  • AACR Report Highlights Cancer Immunotherapy

    The AACR Cancer Progress Report provides a "state-of-the-union" look at where we are in cancer research.

    September 17, 2014| Alexandra Mulvey
  • When AIDS Was a Cancer

    Before AIDS was recognized as an immune disorder, it was seen as a cancer. Find out what…

    August 8, 2014| Matthew Tontonoz
  • Putting a Hurt on Pancreatic Cancer

    CRI postdoc Ingunn Stromnes, PhD, shows that dismantling a tumor’s defense shield makes it vulnerable to immune…

    March 24, 2014| Matthew Tontonoz
Previous Page
1 2 3 4
Next Page
CRI Logo

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog & Media
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute